Jason A Collett Selected Research

Member 3 Group F Nuclear Receptor Subfamily 1

11/2020

Mutation of RORγT reveals a role for Th17 cells in both injury and recovery from renal ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason A Collett Research Topics

Disease

4	Ischemia 11/2020 - 10/2015
3	Fibrosis (Cirrhosis) 01/2018 - 10/2015
2	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 10/2015
2	Inflammation (Inflammations) 01/2017 - 10/2015
1	Critical Illness (Critically Ill) 01/2022
1	Hypoxia (Hypoxemia) 01/2018
1	Microvascular Rarefaction 01/2017
1	Chronic Renal Insufficiency 10/2015
1	Hypertension (High Blood Pressure) 10/2013

Drug/Important Bio-Agent (IBA)

3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2017
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018 - 01/2017
1	Member 3 Group F Nuclear Receptor Subfamily 1IBA 11/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	NADP (NADPH)IBA 01/2018
1	CytokinesIBA 01/2017
1	Losartan (Cozaar)FDA LinkGeneric 01/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 10/2015
1	SaltsIBA 10/2015
1	Type 1 Angiotensin ReceptorIBA 10/2013
1	Angiotensin IIIBA 10/2013
1	Butylated Hydroxytoluene (BHT)IBA 10/2013

Therapy/Procedure

1	Therapeutics 01/2017
1	Nephrectomy 10/2015